MAIA Biotechnology Inc (MAIA) last year’s performance of -31.82% is a clear signal for an entertaining trading season.

Sana Meer

MAIA Biotechnology Inc (AMEX: MAIA) kicked off on Tuesday, up 9.76% from the previous trading day, before settling in for the closing price of $1.23. Over the past 52 weeks, MAIA has traded in a range of $0.87-$2.74.

Healthcare Sector giant saw their annual sales slid by -11.40% over the last five years. While this was happening, its average annual earnings per share was recorded 50.17%. With a float of $28.73 million, this company’s outstanding shares have now reached $34.45 million.

MAIA Biotechnology Inc (MAIA) Breakdown of a Key Holders of the stock

Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of MAIA Biotechnology Inc is 22.41%, while institutional ownership is 6.41%. The most recent insider transaction that took place on Dec 05 ’25, was worth 16,441. In this transaction Director of this company bought 13,740 shares at a rate of $1.20, taking the stock ownership to the 4,580 shares. Before that another transaction happened on Nov 28 ’25, when Company’s Chief Executive Officer bought 50,000 for $1.14, making the entire transaction worth $56,830. This insider now owns 881,421 shares in total.

MAIA Biotechnology Inc (MAIA) Recent Fiscal highlights

In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.2 earnings per share (EPS), higher than consensus estimate (set at -0.35) by 0.15. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.18 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 50.17% per share during the next fiscal year.

MAIA Biotechnology Inc (AMEX: MAIA) Trading Performance Indicators

Take a look at MAIA Biotechnology Inc’s (MAIA) current performance indicators. Last quarter, stock had a quick ratio of 1.18.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.74, a number that is poised to hit -0.13 in the next quarter and is forecasted to reach -0.69 in one year’s time.

Technical Analysis of MAIA Biotechnology Inc (MAIA)

Analysing the last 5-days average volume posted by the [MAIA Biotechnology Inc, MAIA], we can find that recorded value of 0.68 million was better than the volume posted last year of 0.42 million. As of the previous 9 days, the stock’s Stochastic %D was 61.90%.

During the past 100 days, MAIA Biotechnology Inc’s (MAIA) raw stochastic average was set at 43.64%, which indicates a significant decrease from 81.36% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1260 in the past 14 days, which was higher than the 0.0955 volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $1.2896, while its 200-day Moving Average is $1.6024. Now, the first resistance to watch is $1.4417. This is followed by the second major resistance level at $1.5333. The third major resistance level sits at $1.6267. If the price goes on to break the first support level at $1.2567, it is likely to go to the next support level at $1.1633. Now, if the price goes above the second support level, the third support stands at $1.0717.

MAIA Biotechnology Inc (AMEX: MAIA) Key Stats

The company with the Market Capitalisation of 49.99 million has total of 37,032K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -23,250 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -8,900 K.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.